Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
P54274
UPID:
TERF1_HUMAN
Alternative names:
NIMA-interacting protein 2; TTAGGG repeat-binding factor 1; Telomeric protein Pin2/TRF1
Alternative UPACC:
P54274; A7XP29; Q15553; Q8NHT6; Q93029
Background:
Telomeric repeat-binding factor 1, also known as TTAGGG repeat-binding factor 1 or Telomeric protein Pin2/TRF1, plays a crucial role in telomere maintenance. It binds the telomeric double-stranded 5'-TTAGGG-3' repeat, negatively regulating telomere length. As a component of the shelterin complex, it is pivotal in telomere length regulation and protection, safeguarding chromosome ends from DNA damage surveillance and inappropriate processing by DNA repair pathways.
Therapeutic significance:
Understanding the role of Telomeric repeat-binding factor 1 could open doors to potential therapeutic strategies.